Table V.

Treatment group comparisons of estimates of the cumulative incidence function under competing risks and survival probabilities for all disease-free events based on two Weibull distributions. The p-values are calculated using the Wald test.

Years	Treatment group	Cumulative incidence function						Survival function
		Local or regional			Other events			All events
		F̂ci	$\widehat{\mathit{\text{se}}}(F_{\mathit{\text{ci}}})$	p-value	F̂ci	$\widehat{\mathit{\text{se}}}(F_{\mathit{\text{ci}}})$	p-value	F̂surv	$\widehat{\mathit{\text{se}}}(F_{\mathit{\text{surv}}})$	p-value
Four-parameter Weibull
2	tamoxifen	0.018	0.004	0.0001	0.046	0.006	0.059	0.936	0.008	0.0003
	CMFT	0.001	0.001		0.030	0.005		0.969	0.005
5	tamoxifen	0.045	0.007	< 0.0001	0.119	0.011	0.060	0.837	0.012	< 0.0001
	CMFT	0.006	0.003		0.091	0.010		0.903	0.010
10	tamoxifen	0.070	0.010	< 0.0001	0.206	0.017	0.736	0.724	0.016	0.006
	CMFT	0.019	0.006		0.196	0.025		0.785	0.015
Three-parameter restricted beta-Weibull
2	tamoxifen	0.018	0.004	< 0.0001	0.043	0.006	0.093	0.941	0.007	0.002
	CMFT	0.001	0.001		0.029	0.005		0.969	0.005
5	tamoxifen	0.045	0.006	< 0.0001	0.123	0.010	0.027	0.838	0.011	< 0.0001
	CMFT	0.006	0.002		0.091	0.010		0.903	0.010
10	tamoxifen	0.070	0.008	< 0.0001	0.208	0.015	0.562	0.716	0.016	0.002
	CMFT	0.019	0.005		0.196	0.015		0.785	0.016